U.S. Markets closed

Co-Diagnostics, Inc. (CODX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
5.93-0.19 (-3.10%)
At close: 04:00PM EDT
6.09 +0.16 (+2.70%)
After hours: 07:50PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close6.12
Bid5.86 x 1100
Ask6.20 x 1800
Day's Range5.83 - 6.23
52 Week Range3.66 - 11.82
Avg. Volume363,465
Market Cap172.919M
Beta (5Y Monthly)-1.54
PE Ratio (TTM)4.16
EPS (TTM)1.42
Earnings DateNov 15, 2021 - Nov 19, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est19.33
  • Motley Fool

    Why Co-Diagnostics Is Running Higher Today

    Shares of Co-Diagnostics (NASDAQ: CODX) were running 4.6% higher Tuesday morning as of 10:30 a.m. ET on no company-specific news, though it may be getting a boost from an update from the World Health Organization (WHO). The World Health Organization reported this morning there are 5,322 laboratory-confirmed cases of monkeypox. Co-Diagnostics CEO Dwight Egan has said the healthcare company was founded to make low-cost, high-quality tests available wherever they're needed, and it looks "forward to eventually making this test available in affected regions as needed to help slow the spread of the virus through early and accurate detection."

  • PR Newswire

    Co-Diagnostics, Inc. to Present at 29th International Biodetection Technologies Virtual Conference

    Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx,"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it will be presenting this week at the 29th International Biodetection Technologies Conference, held virtually June 28-29, 2022.

  • Zacks

    CoDiagnostics, Inc. (CODX) Surges 5.6%: Is This an Indication of Further Gains?

    CoDiagnostics, Inc. (CODX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.